Asia-Pacific Menopause Federation Consensus Statement on the Management of Menopause 2024
Seng Bin Ang1, Stella Rizalina Sasha Sugianto2, Felicia Clara Jun Hui Tan3
1Family Medicine Service, KK Women's and Children's Hospital, Singapore.
Journal of Menopausal Medicine
|May 10, 2025
Summary
Expert consensus was reached on menopause management for diverse Asia-Pacific women. Menopausal hormone therapy (MHT) is recommended for vasomotor, somatic, or psychological symptoms and osteoporosis prevention.
Area of Science:
- Reproductive Medicine
- Endocrinology
- Public Health
Background:
- Menopause management requires updated guidelines considering Asia-Pacific's diverse population.
- Previous consensus statements need revision based on new evidence and treatment options.
Purpose of the Study:
- To achieve expert consensus on menopause management in the Asia-Pacific region.
- To develop an evidence-based algorithm for clinical practice.
Main Methods:
- Modified Delphi methodology with iterative anonymous surveys.
- Literature search for clinical practice statements on menopause.
- Consensus defined as ≥70% agreement among experts.
Main Results:
- 39 experts from 14 societies participated.
- 85 clinical practice statements achieved consensus.
- Menopausal hormone therapy (MHT) recommended for vasomotor, somatic, and psychological symptoms.
- MHT also recommended for osteoporosis prevention in asymptomatic women.
Conclusions:
- The new consensus statement supersedes the 2008 version.
- Provides guidance for healthcare professionals in the Asia-Pacific region.
- Aims to optimize care for diverse menopausal women.
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
12.1K
08:46Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
5.8K
Related Concept Videos
01:28Menopause
106
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
106
01:22Hormonal Regulation of the Menstrual Cycle
213
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
213
01:37Hypothalamic-Pituitary Axis
58.5K
The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
58.5K
01:18Menses Phase
184
The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
184
01:19The Menstrual Cycle
549
The menstrual cycle is a recurrent sequence of changes in the uterine endometrium, specifically its functional layer, the stratum functionalis. This cycle prepares the uterus for potential pregnancy. This cycle typically spans 21–35 days, averaging 28 days, and aligns with the ovarian cycle, regulated by fluctuating levels of ovarian hormones, primarily estrogen and progesterone.
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
The menstrual phase occurs from days 1 to 5 and involves the shedding of the stratum functionalis, as a...
549
01:30Hormonal Control of the Ovarian Cycle
344
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
344